What type of study is this?

This is a In Vitro Study study.

What question did this study set out to answer?

This research aims to identify epigenetic mechanisms limiting viral latency conversion in EBV+ lymphomas and explore potential therapeutic interventions.

December 8, 2025Blood

Epigenetic silencing via SP140 and H3K27me3 restricts immunogenic viral antigen expression in EBV+ lymphomas

View Full Paper

Ask AI

Bookmark

This research aims to identify epigenetic mechanisms limiting viral latency conversion in EBV+ lymphomas and explore potential therapeutic interventions.
RNA-sequencing on EBV+ BL cells to compare sensitive vs. resistant cells to DCB
Evaluation of effects of SP140 inhibitor GSK761 on viral latency in EBV+ BL cells
ChIP-qPCR analysis of H3K27me3 levels at viral promoters
In vivo treatment of BL xenografts with DCB and EZH2 inhibitor tazemetostat
Flow cytometry to assess latency profiling and T-cell activation.
Combined treatment with DCB and GSK761 increased latency conversion to II/III cells
DCB plus EZH2 inhibition significantly enhanced immunogenicity in BL cells
Higher levels of H3K27me3 found in resistant cells compared to sensitive cells
DCB plus TAZ improved the proportion of LMP1-expressing cells in in vivo models
Increased IFNg production observed from T cells exposed to treated BL cells.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

RNA-sequencing reveals that DNMT1 and decitabine improve immunogenic viral antigen expression in EBV+ lymphomas, suggesting a therapeutic strategy.

Cite This Study

Lisa Roth (2025) studied this question.

synapsesocial.com/papers/693624d44fa91c937236d00d https://doi.org/10.1182/blood-2025-326

View Full Paper

Ask AI

Bookmark

Implication

RNA-sequencing reveals that DNMT1 and decitabine improve immunogenic viral antigen expression in EBV+ lymphomas, suggesting a therapeutic strategy.

Epigenetic silencing via SP140 and H3K27me3 restricts immunogenic viral antigen expression in EBV+ lymphomas

Key Points

Discussion

Implication

Cite This Study

Epigenetic silencing via SP140 and H3K27me3 restricts immunogenic viral antigen expression in EBV+ lymphomas

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider